Search Results - "Manuel, Oriol"

Preemptive therapy versus universal prophylaxis: Time for reconciliation? by Kampouri, Eleftheria, Manuel, Oriol

Get full text

Impact of COVID‐19 in solid organ transplant recipients by Danziger‐Isakov, Lara, Blumberg, Emily A., Manuel, Oriol, Sester, Martina

“…The coronavirus disease 2019 (COVID‐19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) exploded onto the world stage in…”
Get full text

COVID‐19: A global transplant perspective on successfully navigating a pandemic by Kumar, Deepali, Manuel, Oriol, Natori, Yoichiro, Egawa, Hiroto, Grossi, Paolo, Han, Sang‐Hoon, Fernández‐Ruiz, Mario, Humar, Atul

“…The COVID‐19 pandemic has rapidly evolved and changed our way of life in an unprecedented manner. The emergence of COVID‐19 has impacted transplantation…”
Get full text

Clinical manifestations and immune markers of non-HIV-related CMV retinitis by Passarin, Olga, Hoogewoud, Florence, Manuel, Oriol, Guex-Crosier, Yan

“…Since the HIV epidemic in the 1980s, CMV retinitis has been mainly reported in this context. CMV retinitis in persons living with HIV is usually observed when…”
Get full text

Antimicrobial stewardship programs in solid‐organ transplant recipients in Switzerland by Bielicki, Julia A., Manuel, Oriol

“…Introduction Antimicrobial stewardship programs (ASPs) are essential for minimizing the emergence of antimicrobial resistance, while improving patient…”
Get full text

Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial by Mombelli, Matteo, Rettby, Nils, Perreau, Matthieu, Pascual, Manuel, Pantaleo, Giuseppe, Manuel, Oriol

“…The use of vaccines with higher doses of antigen is an attractive strategy to improve the immunogenicity of influenza vaccination in transplant recipients…”
Get full text

SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know by Giannella, Maddalena, Pierrotti, Lígia C, Helanterä, Ilkka, Manuel, Oriol

“…In response to the COVID-19 pandemic, SARS-CoV-2 vaccines have been developed at an unparalleled speed, with 14 SARS-CoV-2 vaccines currently authorized…”
Get more information

Infections after chimeric antigen receptor (CAR)‐T‐cell therapy for hematologic malignancies by Kampouri, Eleftheria, Little, Jessica S., Rejeski, Kai, Manuel, Oriol, Hammond, Sarah P., Hill, Joshua A.

“…Background Chimeric antigen receptor (CAR)‐T‐cell therapies have revolutionized the management of acute lymphoblastic leukemia, non‐Hodgkin lymphoma, and…”
Get full text

Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: An observational retrospective study by Regina, Jean, Papadimitriou-Olivgeris, Matthaios, Burger, Raphaël, Le Pogam, Marie-Annick, Niemi, Tapio, Filippidis, Paraskevas, Tschopp, Jonathan, Desgranges, Florian, Viala, Benjamin, Kampouri, Eleftheria, Rochat, Laurence, Haefliger, David, Belkoniene, Mehdi, Fidalgo, Carlos, Kritikos, Antonios, Jaton, Katia, Senn, Laurence, Bart, Pierre-Alexandre, Pagani, Jean-Luc, Manuel, Oriol, Lhopitallier, Loïc

“…This study aims to describe the epidemiology of COVID-19 patients in a Swiss university hospital. This retrospective observational study included all adult…”
Get full text

Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: a viewpoint in 2020 by Lortholary, Olivier, Fernandez-Ruiz, Mario, Baddley, John W, Manuel, Oriol, Mariette, Xavier, Winthrop, Kevin L

“…Biological therapies have improved the outcomes of several major inflammatory, autoimmune and also neoplastic disorders. Those directed towards cytokines or…”
Get more information

Things We Do for No Reason™: Computed tomography of the head before lumbar puncture in low-risk adults and children by Regina, Jean, Manuel, Oriol

Get full text

The future of SARS‐CoV‐2 vaccines in transplant recipients: To be determined by Blumberg, Emily A., Manuel, Oriol, Sester, Martina, Ison, Michael G.

“…This editorial discusses the impact of preliminary results of COVID‐19 vaccination studies on transplant recipients…”
Get full text

Antibody response and intra‐host viral evolution after plasma therapy in COVID‐19 patients pre‐exposed or not to B‐cell‐depleting agents by Gachoud, David, Pillonel, Trestan, Tsilimidos, Gerasimos, Battolla, Dunia, Dumas, Dominique, Opota, Onya, Fontana, Stefano, Vollenweider, Peter, Manuel, Oriol, Greub, Gilbert, Bertelli, Claire, Rufer, Nathalie

“…Summary Administration of plasma therapy may contribute to viral control and survival of COVID‐19 patients receiving B‐cell‐depleting agents that impair…”
Get full text

Immune Monitoring for CMV in Transplantation by Yong, Michelle K., Lewin, Sharon R., Manuel, Oriol

“…Purpose of Review Immune monitoring to determine when and how the recovery of cytomegalovirus (CMV)-specific T-cells occurs post-transplantation may help…”
Get full text

Impact of different urinary tract infection phenotypes within the first year post‐transplant on renal allograft outcomes by Brune, Jakob E., Dickenmann, Michael, Wehmeier, Caroline, Sidler, Daniel, Walti, Laura, Golshayan, Dela, Manuel, Oriol, Hadaya, Karine, Neofytos, Dionysios, Schnyder, Aurelia, Boggian, Katia, Müller, Thomas, Schachtner, Thomas, Khanna, Nina, Schaub, Stefan

“…In this study, we investigated the clinical impact of different urinary tract infection (UTI) phenotypes occurring within the first year after renal…”
Get full text

Microbial metagenome of urinary tract infection by Moustafa, Ahmed, Li, Weizhong, Singh, Harinder, Moncera, Kelvin J., Torralba, Manolito G., Yu, Yanbao, Manuel, Oriol, Biggs, William, Venter, J. Craig, Nelson, Karen E., Pieper, Rembert, Telenti, Amalio

“…Urine culture and microscopy techniques are used to profile the bacterial species present in urinary tract infections. To gain insight into the urinary flora,…”
Get full text

Antibiotic Therapy for Difficult-to-Treat Infections in Lung Transplant Recipients: A Practical Approach by van den Bogaart, Lorena, Manuel, Oriol

“…Lung transplant recipients are at higher risk to develop infectious diseases due to multi-drug resistant pathogens, which often chronically colonize the…”
Get full text

Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study by Walti, Laura N., Mugglin, Catrina, Sidler, Daniel, Mombelli, Matteo, Manuel, Oriol, Hirsch, Hans H., Khanna, Nina, Mueller, Nicolas, Berger, Christoph, Boggian, Katia, Garzoni, Christian, Neofytos, Dionysios, Delden, Christian, Hirzel, Cédric

“…Posttransplant lymphoproliferative disorder (PTLD) is a serious complication of solid organ transplantation (SOT). Most PTLD cases are associated with…”
Get full text

Emergence of letermovir resistance in solid organ transplant recipients with ganciclovir resistant cytomegalovirus infection: A case series and review of the literature by Hofmann, Eveline, Sidler, Daniel, Dahdal, Suzan, Bittel, Pascal, Suter‐Riniker, Franziska, Manuel, Oriol, Walti, Laura N., Hirzel, Cédric

“…Ganciclovir (GCV)‐resistant cytomegalovirus (CMV) infection is a common problem among solid organ transplant (SOT) recipients without prior CMV immunity (CMV…”
Get full text

Current management of SARS-CoV-2 infection in solid organ transplant recipients: Experience derived from an ESGICH-ESOT survey by Visentin, Alessandro, Pickavance, Elise, San-Juan, Rafael, Grossi, Paolo Antonio, Manuel, Oriol, Aguado, Jose M

“…Solid organ transplant (SOT) recipients have a poorer SARS-CoV-2 vaccine response and higher risk for COVID-19-associated complications. However, there is no…”
Get full text